High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial
COVID-19에 따른 급성 호흡곤란 증후군에 대한 고용량 덱사메타손 치료: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
active cancer
acute respiratory distress
acute respiratory distress syndrome
Adult patients
advance directives
Advanced cancer
age
alpha error
anticipated
approved
ARDS
assessment
assigned
bilateral pulmonary infiltrates
Blinding
block
breast-feeding
Buenos Aires
capture
cardiac disease
CEMIC
clinical
clinical trial
code
Complete
concealed
Confirmed
COVID-19
COVID-19, Dexamethasone, Acute Respiratory Distress Syndrome, Randomised controlled trial, protocol, Steroids
delirium
develop
Dexamethasone
diagnosis of SARS-CoV-2
directive
discharge
disease
dissemination
do not resuscitate
dose
Effectiveness
element
End-Expiratory Pressure
evaluate
exclusion criteria
Expiratory Pressure
explained
failure
followed by
Frequency
glucocorticoid
Glucocorticoids
group
hemodynamic
High dose
HIV infection
hypoxemic
Hypoxemic respiratory failure
ICU
Immunosuppression
Immunosuppressive agents
include
inclusion criteria
Infection
Informed consent
intensive care unit
International
legal guardian
Length
less
Life expectancy
local Ethics Committee
mechanical ventilation
Mortality
multicenter
muscle weakness
Nosocomial infection
Nosocomial infections
number
objective
open
open label
open trial
other disease
other diseases
outcome
Palliative care
PaO
parallel group
participant
Participation
Patient
Patient care
platform
Pneumonia
Positive end-expiratory pressure
power
power of 80%
Prednisone
pressure
Prone position
protocol
R language
random
randomised
randomised controlled trial
randomization
Randomized
randomized clinical trial
receive
recruitment
Registered
renal
renal disease
respiratory
respiratory distress
Respiratory distress syndrome
Respiratory failure
resuscitate order
RT-PCR
Sample size
SARS-COV-2 infection
SARS-CoV-2 pneumonia
secondary
Secondary outcomes
secondary to
sequence
Sequential Organ Failure Assessment
severe immunosuppression
SOFA
Standard deviation
status
Stratified randomization
Study protocol
subject
Support
syndrome
table
terminal
Terminal disease
title
Treatment
treatment groups
Trial
Trial registration
two-tailed alpha error
Variation
ventilator
ventilator-free day
Ventilator-free days
ventilatory
Version
viral shedding
weakness
website
women
[DOI] 10.1186/s13063-020-04646-y PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04646-y PMC 바로가기 [Article Type] Letter